Call for Abstract

5th International Conference and Exhibition on Metabolomics, will be organized around the theme “Fifty Shades of Metabolomics and Methodological Development ”

Metabolomics Congress 2016 is comprised of 22 tracks and 102 sessions designed to offer comprehensive sessions that address current issues in Metabolomics Congress 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Metabolic profiling is the estimation in organic frameworks of the supplement of low-atomic weight metabolites and their intermediates that mirrors the dynamic reaction to hereditary change and physiological, pathophysiological, and/or formative boosts. The estimation and elucidation of the endogenous metabolite profile from an organic example (normally pee, serum, or natural tissue remove) have given numerous chances to research the progressions prompted by outside boosts (e.g., drug treatment) or improve our insight into inalienable organic variety inside of subpopulations.

Metabolic profiling can supplement routine systems and other "omics" advances in researching preclinical medication improvement issues. Contextual investigations will represent the estimation of metabolic profiling in enhancing our comprehension of phospholipidosis and peroxisome multiplication. A key message will be that metabolic profiling offers immense potential to highlight biomarkers and instruments in backing of toxicology and pathology examinations in preclinical medication advancement.

Metabolomics is an information escalated discipline whose work process is described by broad utilization of databases. Database applications range from compound recognizable proof (e.g. precise mass, GC-EI range or MS/MS range examination) to information coordination and perception (task of mixes to responses, pathways, cell compartments, etc.).Metabolomics is an infant cousin to genomics and proteomics. In particular, metabolomics includes the fast, high throughput portrayal of the little particle metabolites found in a life form. The metabolome is firmly fixing to the genotype of a creature, its physiology and its surroundings (what the life form eats or inhales), metabolomics offers a special chance to take a gander at genotype-phenotype and also genotype-envirotype connections. Metabolomics is progressively being utilized as a part of an assortment of wellbeing applications including pharmacology, pre-clinical medication trials, toxicology, transplant observing, infant screening and clinical science. In any case, a key confinement to metabolomics is the way that the human metabolome is not in any way all around portrayed.

  • Track 2-1NMR spectral databases
  • Track 2-2MS or MS/MS spectral databases
  • Track 2-3Compound databases
  • Track 2-4Pathway databases
  • Track 2-5Comprehensive metabolomic databases
  • Track 2-6Yeast metabolome database
  • Track 2-7The human serum metabolome database
  • Track 2-8The urine metabolome database

Metabolomics is a generally youthful branch of "omics" science worried with the orderly investigation of the compound items or metabolites that cells and living beings produce. Since metabolites are the downstream results of various extensive or far reaching cooperations, the metabolome (the total of all metabolites in a living being) can be an exceptionally touchy measure of a living being's phenotype. This has made metabolomics especially helpful in the investigation of environment-quality associations, the ID of illness biomarkers and the revelation of medications. Not at all like its more seasoned "omics" cousins, where finish or close finish scope of the genome or proteome is genuinely standard, metabolomics still battles to cover even a modest portion of the metabolome. Without a doubt, most human metabolomic examines distributed today, even those misusing the most recent and most touchy LC-MS/MS advances, ordinarily succeed in distinguishing or describing less than 100 mixes. This relates to under 1% of the known human metabolome. With an end goal to enhance this circumstance, we (and others) have begun to embrace the methodical portrayal of different human biofluid metabolomes. This incorporates the human cerebrospinal liquid metabolome the human spit metabolome and the human serum metabolome. We have now turned our regard for portraying the human pee metabolome.

Metabolites can serve as a metabolic sickness biomarker. A location of such biomarkers assumes a noteworthy part in the investigation of biochemical response and flagging systems. Metabolic profiling, metabolomic and metabonomic concentrates for the most part include the multi component investigation of organic liquids, tissue and cell separates utilizing NMR spectroscopy and/or mass spectrometry (MS). Metabolic profiling (metabolomics/metabonomics) is the estimation in organic frameworks of the supplement of low-atomic weight metabolites and their intermediates that mirrors the dynamic reaction to hereditary change and physiological  , pathophysiological, and/or formative jolts. The present advancements in metabolomics and metabolic profiling advances have prompted the disclosure of a few new metabolic biomarkers. The Human Metabolome Database (HMDB) is as of now the most finish and extensive curated gathering of human metabolite and human digestion system information on the planet. It contains records for more than 2180 endogenous metabolites with data accumulated from a large number of books, diary articles and electronic databases. Notwithstanding its far reaching writing determined information, the HMDB likewise contains a broad accumulation of exploratory metabolite focus information gathered from many mass spectra (MS) and Nuclear Magnetic reverberation (NMR) metabolomic examinations performed on pee, blood and cerebrospinal liquid examples. The HMDB is intended to address the wide needs of organic chemists, clinical scientific experts, doctors, restorative geneticists, nutritionists and individuals from the metabolomics group

The metabolome is characterized as the full supplement of little particle metabolites found in a particular cell, organ, or creature. The most fascinating potential use of single-cell metabolomics might be in the region of growth. In different fields where single-cell metabolomics is required to have an effect are frameworks science, foundational microorganism research, maturing, and the improvement of medication resistance; all the more for the most part, it could be utilized to find cells' compound procedures for adapting to concoction or natural anxiety. In respect to other single-cell "- omics" estimations, metabolomics gives a more prompt and element photo of the usefulness (i.e., of the phenotype) of a cell, however is seemingly likewise the most hard to quantify. Single-cell investigation of metabolites by mass spectrometry (MS) is trying because of the extremely restricted volume and inborn atomic unpredictability of the specimen. Quantitative metabolomic examination of individual cells gives data on the metabolic heterogeneity of cells unattainable by total investigation of various cells. Contingent upon the ionization technique, MS can offer quantitative examination for an expansive class of metabolites showing both high affectability and selectivity. Laser removal electrospray ionization (LAESI) has been effectively abused to break down metabolites from expansive scope of organic examples, including single cells and little cell populaces.

Mass spectrometry (MS) has developed as a basic segment in metabolomics which tries to answer natural inquiries through extensive scale subjective and quantitative investigations of the metabolome. MS based metabolomics procedures offer a brilliant mix of affectability and selectivity, and they have turned into a crucial stage in science and metabolomics. The rising field of metabolomics, expecting to describe little particle metabolites present in natural frameworks, guarantees enormous potential for various ranges, for example, drug, ecological sciences, agronomy, and so on. The quickly developing region of "metabolomics," in which an expansive number of metabolites from body liquids, cells or tissue are identified quantitatively, in a solitary step, guarantees massive potential for various orders including early sickness finding, treatment checking, frameworks science, drug revelation and wholesome science. In light of its capacity to identify an extensive number of metabolites in place organic examples reproducibly and quantitatively, atomic attractive reverberation (NMR) spectroscopy has risen as a standout amongst the most effective logical systems in metabolomics.

Urine metabolomics has as of late risen as a conspicuous field for the revelation of non-intrusive biomarkers that can recognize unpretentious metabolic errors because of a particular malady or helpful mediation. Urine, contrasted with different biofluids, is described by its simplicity of accumulation, extravagance in metabolites and its capacity to reflect uneven characters of every biochemical pathway inside of the body. Urine gathering for metabolomic investigation, tests must be instantly solidified to extinguish any biogenic and/or non-biogenic concoction responses. Consolidated with the subjective and quantitative abilities of MS, and because of the nonstop changes in its related advances fluid chromatography (LC)- MS is unequivocally the most used and the most educational logical instrument utilized in Urine metabolomics. The Urine Metabolome database is an openly accessible electronic database containing definite data about ~3100 little atom metabolites found in human Urine alongside ~3900 focus values. Every metabolite section contains more than 110 information fields and a significant number of them are hyperlinked to different databases (KEGG, PubChem, ChEBI, Chemspider, DrugBank, PDB and Uniprot). The data incorporates writing and tentatively determined substance information, clinical information and sub-atomic/organic chemistry information.

Cancer is an overwhelming sickness that changes the digestion system of a cell and the encompassing milieu. Metabolomics in pharmaceutical examination turning into an inexorably mainstream instrument in the life sciences since it is a generally quick and precise procedure that can be connected with either a specific center or in a worldwide way to uncover new learning about organic frameworks.. NFCR has conveyed more than $330 million in subsidizing to growth research prompting various leaps forward, including counteractive action methodologies, prior analytic systems, and new anticancer medications and treatments. The Division of Cancer Biology (DCB) bolsters and encourages fundamental examination in every aspect of tumor science at scholastic establishments and exploration establishments over the United States and abroad. As a major aspect of the National Cancer Institute, the Federal Government's foremost office for growth research and preparing, DCB gives financing to research that examines the fundamental science behind all events of Cancer. Current metabolomic approaches is being utilized to find symptomatic Cancer biomarkers in the clinic, to find pathways included in disease that could be utilized for new targets and to screen metabolic biomarkers amid remedial mediation. Concentrating on growth through metabolomics could uncover metabolite stage for hearty approval of biomarkers for Cancer that could be helpful for its future forecast, conclusion and treatment. There have been numerous novel ways to deal with cancer therapeutics that have utilized a scope of various explanatory stages. At the point when Cancer digestion system meets frameworks science system models might manual for growth treatment.

Related Conferences: 5th World Congress on Cancer Therapy, September 28-30, 2015 Atlanta, USA; Cancer  Diagnostics Conference & Expo, June 13-15, 2016, Rome, Italy; International Conference on Cancer Immunology and Immunotherapy Conference July 28-30, 2016 Melbourne, Australia; 9th  Indo Global Summit on Cancer Therapy, November 02-04, 2015, Hyderabad, India; 2nd International Conference on Breast Cancer , September 19-21, 2016 Phoenix, USA; Novel Cancer Therapeutics Summit, November 16-17, 2016 San Francisco, USA; European Lung Cancer Conference, April 13-16, 2016, Geneva, Switzerland; Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, March 6–10, 2016, Whistler, Canada; IMPAKT  Breast Cancer Conference,  May 12 - 14 2016, Brussels, Belgium.

  • Track 8-1Cancer metabolomics and diagnostic biomarkers
  • Track 8-2Current metabolomic methodologies
  • Track 8-3Applications of metabolomics in oncology and biomarker discovery
  • Track 8-4Metabolite platform for robust validation of biomarkers
  • Track 8-5Metabolomics in pharmaceutical research
  • Track 8-6Cancer metabolism meets systems biology
  • Track 8-7Novel approaches to cancer therapeutics

Metabolomics and lipidomics, intense apparatuses in frameworks science, expect to screen little metabolites present in organic examples. Contrasts in the species or measures of metabolites can be utilized to portray phenotypes and natural reactions to annoyances (ailments, hereditary adjustments, or nutritious and pharmacological medications). The Thermo Scientific TSQ arrangement mass spectrometer instrument family, joined with high determination GC or UHPLC, gives unrivaled adaptability and affectability to chose particle response checking (SRM) tests for measuring endogenous metabolites and lipids utilizing Thermo Scientific TraceFinder and LC Quan programming. Translational Biomarker Discovery Core incorporate distinguishing, approving and creating pre-clinical biomarkers for building up the vicinity of ailment, observing reduction status, deciding the viability of particular remedial conventions, and controlling the choice of particular helpful mediations. Connecting the consequences of biomarker studies utilizing protein-protein association methodologies can help with frameworks science approaches and could prompt theory era and recognizable proof of new medication targets. Science Minister David Willetts has declared £48 million of new speculation to store research ventures went for handling wellbeing issues

Related Conferences: 2nd International Conference on Current Trends in Mass Spectrometry May 09-11, 2016 Chicago, USA; Asia Pacific Mass Spectrometry Congress October 13-15, 2016 Kuala Lumpur, Malaysia; 7th International Conference on Biomarkers&Clinical Research, November 28-30, 2016, Baltimore, USA; 7th International Conference and Exhibition on Analytical & Bioanalytical Techniques, Sept 29-Oct 01, 2016 , Miami, USA; 2nd International Conference on Genetic and Protein Engineering ,November 14-16, 2016 Atlanta, USA; LIPID MAPS Annual Meeting 2016: Lipidomics Impact on Metabolic, Cancer, Cardiovascular and Inflammatory Diseases, May 17 - 18, 2016, La Jolla, USA; 64th ASMS Conference, 5–9 June 2016  San Antonio, TX; 21st International Mass Spectrometry Conference (IMSC 2016),August 20-26, 2016,Toronto, Canada; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan

  • Track 9-1Translational biomarker discovery
  • Track 9-2Metabolic interactions
  • Track 9-3Clinical applications of metabolomics
  • Track 9-4Metabolomics and mass spectrometry
  • Track 9-5Mass spec in clinical microbiolgy
  • Track 9-6Forensic analysis

Metabolomics is connected to research a few human illnesses, to enhance their determination and aversion, and to outline better helpful systems. Metabolomic profiling has been utilized to distinguish novel biomarkers and mechanisms of cardiovascular disease risk. Nourishment and Metabolism Center and Center for Human Genetics at Duke University where the examination is going ahead with National Institutes of Health awards . Metabolomics can give certain preferences in respect to other "omics" advancements (genomics, transcriptomics, proteomics) in diabetes research. CEDAM (Center for Endocrinology, Diabetes and Metabolism) exploration is focused on a seat to-bedside approach, taking examination through from fundamental science disclosure to clinical application. This is encouraged by ebb and flow MRC Experimental Medicine and Biomarker Grants and improved by the nearby vicinity of lab offices, Wellcome Trust Clinical Research Facility and the Queen Elizabeth Hospital (University Hospital NHS Foundation Trust). Metabolomic approach gives novel experiences into the mechanistic studies of antitumor medications from a point particular from traditional medicine investigations. Different new advancements have be utilized for technique improvement of metabolomics. Specialized advances have prodded the use of metabolomics in an assortment of various examination zones spreading over essential, biomedical, and clinical sciences.

Related Conferences:  6th International Metabolomics Conference, November 28-30, 2016 Chicago, USA; 5th World Congress on Neurology and Therapeutics, March 14-16, 2016, Rome, Italy; International Conference on Cardiovascular Nursing, May 5-7,2016, Chicago, USA;11th International Conference on Targeting Diabetes and Novel Therapeutics, October 17-19, 2016 Kuala Lumpur, Malaysia; Epigenetic and Metabolic Regulation of Aging and Aging-Related Diseases, May 1-5, 2016,Santa Fe, USA; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan; 18th International Conference on Genetics and Molecular Biology, October 10 - 11 2016, Osaka, Japan; 13th International Congress of Human Genetics, April 3-7 2016, Kyoto, Japan.

  • Track 10-1Metabolomics in cardiovascular diseases
  • Track 10-2Metabolomics in neuroscience and neurology
  • Track 10-3Metabolism and diabetes
  • Track 10-4Metabolomics and mechanistic study
  • Track 10-5Methodology development of metabolomics
  • Track 10-6Metabolomics and traditional medicine study
  • Track 10-7Metabolic and endocrine science

Metabolomics is the examination of endogenous and exogenous low atomic mass metabolites inside of a cell, tissue, or biofluid of a life form in light of an outer stressor. The sub-control of environmental metabolomics is the utilization of metabolomic strategies to investigate the connections of life forms with their surroundings. Drug metabolism system is the procedure by which the body separates and changes over pharmaceutical into dynamic concoction substances. Toxicology is a branch of Medical Science that arrangements with the impacts of synthetic compound utilized as a part of the conclusion, treatment, or counteractive action of ailment or other unusual condition on the body. Plant Metabolomics is to contemplate the plant framework at the sub-atomic level giving non-one-sided characterization of the total metabolite pool (metabolome) of plants under particular conditions. Using Metabolomics, a better understanding of the correlation between genes and the biochemical composition of a plant tissue in response to its environment (phenotype) can be obtained, and this information can be further used to assess gene function (genotype). Four joint U.S. also, Japanese research groups have been recompensed subsidizing totaling about $12 million (about Yen 960 million) to grow new naturally well disposed strategies to expand the creation of renewable biofuel and lessen pesticide use.

Related Conferences:2nd International Conference on Current Trends in Mass Spectrometry May 09-11, 2016 Chicago, USA; Asia Pacific Mass Spectrometry Congress October 13-15, 2016 Kuala Lumpur, Malaysia; Global Summit on Plant Science, October 31-November 02, 2016 Baltimore, USA San Antonio, USA; International Conference on Plant Physiology, June 09-11, 2016, Dallas, USA; International Conference on Clinical and Molecular Genetics, November 28-30, 2016, Chicago, USA; HPLC 2016, June 19-24, 2016, San Francisco, USA; 21st International Mass Spectrometry Conference (IMSC 2016),August 20-26, 2016,Toronto, Canada; Plant Metabolic Engineering, July 19-24, 2016, Waterville Valley, NH; 11th International Congress of  Plant Molecular Biology (IPMB), October 25-30, 2015 Foz do Iguazu, Brazil

  • Track 11-1Green systems biology
  • Track 11-2Recent developments in environmental metabolomics
  • Track 11-3NMR-based metabolomics in wine science
  • Track 11-4Toxicology and drug metabolism
  • Track 11-5Linking metabolomics with quality traits in crop plants
  • Track 11-6Applications of metabolomics in plant metabolomics
  • Track 11-7Toxicometabolomics

Unlike other ‘omics’ technologies (genomics, proteomics…etc), metabolomics gives organic understanding that mirrors an individual's one of a kind hereditary unique mark, as well as way of life, eating routine and environment. Utilizing metabolomics, scientists can quantitatively dissect non-hereditary variables that are included in postgenomic and posttranscriptional change. Nutritional metabolomics is quickly developing to utilize little atom substance profiling to bolster incorporation of eating regimen and sustenance in complex biosystems research. Nutrigenomics is a branch of nutritional genomics and is the study of the effects of foods and food constituents on gene expression. Foodomics has been recently defined as a new discipline that studies food and nutrition domains through the application of advanced omics technologies in which MS techniques are considered indispensable. Applications of Foodomics include the genomic, transcriptomic, proteomic, and/or metabolomic study of foods for compound profiling, authenticity, and/or biomarker-detection related to food quality or safety; the development of new transgenic foods, food contaminants, and whole toxicity studies; new investigations on food bioactivity, food effects on human health. The University of Michigan Nutrition Obesity Research Center (UM NORC) started in 2010, supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The UM NORC is one of 12 U.S. focuses intended to move and backing translational, multi-disciplinary exploration in heftiness and sustenance, over the continuum of fundamental science to applications in people (solution) and populations (public health).

Related Conferences: 5th International Conference on Clinical Nutrition, San Antonio, November 28-30, 2016; USA; 6th International Conference and Exhibition on Diet and Nutrition, August 18-20, 2016 London, UK; 2nd International Conference on Lipid Science & Technology, October 06-08, 2016 Maimi, USA; International Conference on Environmental Toxicology and Ecological Risk Assessment , August 25-26, 2016 Sao Paulo, Brazil; 2nd International Conference on Livestock Nutrition, July 21-22, 2016 Brisbane, Australia; 10th Congress of the International Society of Nutrigenetics & Nutrigenomics (ISNN), May 22-26, 2016, Tel Aviv, Israel; Max Rubner Conference 2016: Food Metabolomics, October 10-12,2016, Germany.

  • Track 12-1Metabolomics of genetically modified crops
  • Track 12-2Metabolomics in nutrition research
  • Track 12-3Dietary metabolites and cellular metabolism
  • Track 12-4Nutrigenomics and plant functional genomics
  • Track 12-5Food safety and contamination assessment using metabolomics
  • Track 12-6Applications of metabolomics to food processing

Metabolomics, the post-genomic investigation of the particles and procedures that make up digestion system, shows up as a possibly radical better approach for looking at science and illness. Precision Medicine is a way to deal with finding and creating medications and antibodies that conveys unrivaled results for patients, by incorporating clinical and sub-atomic data to comprehend the organic premise of infection. Pharmacometabolomics informs and compliments pharmacogenomics and together they give building pieces to Quantitative and Systems Pharmacology. Precision offers next generation solutions to maximize your success in translational research. The advent of massive parallel sequencing is responsible of a paradigm shift in biomarker discovery and clinical trial design on the way to what is now called "biomarker-driven cancer medicine" or "precision medicine."  Complementing hearty ventures to comprehensively bolster exploration, improvement, and advancement, the President's 2016 Budget will give a $215 million speculation to the National Institutes of Health (NIH), together with the Food and Drug Administration (FDA), and the Office of the National Coordinator for Health Information Technology (ONC) to backing this exertion.

Related Conferences: International Conference on Precision Medicine, November 03-05, 2016, Baltimore, USA; 5th International Conference on Translational Medicine, November 17-19 2016, San Francisco , USA; 4th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics, September 19-21 2016, Phoenix, USA; 2nd International Conference and Exhibition on Molecular Medicine and Diagnostics, September 26-28, 2016 Miami, USA; International Conference onMedicinal Chemistry&Computer Aided Drug DesigningDecember 01-03, 2016 Chicago, USA; International Conference on General Medicine & Dental Practise, Nov 7-9, 2016 Istanbul, Turkey;  Precision Medicine, March 7 – 9 2016,San Francisco, CA;The Personalized Medicine World Conference (PMWC) 2016, San Francisco, USA; 18th International Conference on Genetics and Molecular Biology, October 10 - 11 2016, Osaka, Japan; 13th International Congress of Human Genetics, April 3-7 2016, Kyoto, Japan.

  • Track 13-1Pharmacometabolomics and precision medicine
  • Track 13-2Clinical applications of precision medicine
  • Track 13-3Precision medicine for mental disorders
  • Track 13-4Advanced biomarkers for recision Medicine
  • Track 13-5Biomarker analytics for translational research
  • Track 13-6Molecular biological profiling

Metabolomics, alternately metabonomics, a rising field of biochemical exploration, is a reciprocal procedure to genomics, transcriptomics, and proteomics. Direct quantitative estimations of metabolite expressions in pee, serum, plasma, and tissue are crucial for the investigation of organic procedures in typical and illness states. Subsequent to the quantity of metabolites in a natural example is extensive partition science assumes an imperative part in metabolomic research. Atomic attractive reverberation (NMR) spectroscopy is especially capable for focused investigation since it is quantitative, reproducible, and suitable for complex examples, for example, blood, pee, or tissue removes with practically zero preparing. Thermo Fisher, AB SCIEX, and Bruker likewise offer instruments for imaging MS, additionally called MALDI imaging. To meet difficulties of searchability and information reconciliation, the metabolomics group has a few activities to build up information vaults. Cases are Metabolights in the United Kingdom, bolstered by the European COSMOS (COordination of Standards in MetabOlomicS) consortium that is creating metabolomics information norms, and Metabolomics Workbench, which means to be the database for NIH-subsidized metabolomics ventures. Thermo Fisher teams up with Fiehn on mzcloud.org, a free community database that includes actual and virtual MS spectra with unknown compounds to be annotated as they are identified.

Related Conferences: 2nd International Conference on Current Trends in Mass Spectrometry May 09-11, 2016 Chicago, USA; Asia Pacific Mass Spectrometry Congress October 13-15, 2016 Kuala Lumpur, Malaysia; 7th International Conference on Biomarkers&Clinical Research, November 28-30, 2016, Baltimore, USA; 7th International Conference and Exhibition on Analytical & Bioanalytical Techniques, Sept 29-Oct 01, 2016 , Miami, USA; 2nd International Conference on Genetic and Protein Engineering ,November 14-16, 2016 Atlanta, USA; LIPID MAPS Annual Meeting 2016: Lipidomics Impact on Metabolic, Cancer, Cardiovascular and Inflammatory Diseases, May 17 - 18, 2016, La Jolla, USA; 64th ASMS Conference, 5–9 June 2016  San Antonio, TX; 21st International Mass Spectrometry Conference (IMSC 2016),August 20-26, 2016,Toronto, Canada; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan

  • Track 14-1High-throughput analysis
  • Track 14-2Ultra performance liquid chromatography UPLC
  • Track 14-3NMR and LC-MS based techniques
  • Track 14-4Metabolic profiling and biomarkers
  • Track 14-5Biological signature (fingerprint) or mapping pathways
  • Track 14-6Ion mobility spectrometry for quantitative and qualitative applications

Metabolomic studies can prompt improved comprehension of illness instruments and to new diagnostic markers  and also upgraded comprehension of drug for medication or xenobiotic effect and increased ability to predict individual variation in drug response phenotypes. Howard University Center for Computational Biology and Bioinformatics (CCBB) is to energize and advance the utilization of computational ways to deal with the investigation of biomedical and infection forms. New software and increasingly sophisticated NMR metabolite spectral databases are propelling the interesting capacities of NMR spectroscopy to recognize and evaluate little particles in answer for investigations of metabolite biomarkers and metabolic flux. NIH Awards $1.6M to Fund microRNA Biomarker Research in Cancer, Alzheimer's Disease . The Bill and Melinda Gates Foundation today reported $7.7 million in subsidizing for 10 new allows to distinguish biomarkers for diagnosing tuberculosis (TB) in low-asset settings. NMR metabolomics to demonstrate that divergent environmental signals are transduced into common metabolomic changes that are "sensed" by metabolite responsive regulators.


Related Conferences: 7th International Conference on Biomarkers&Clinical Research, November 28-30, 2016, Baltimore, USA; 6th International Conference & Expo on Proteomics March 29-30, 2016, Atlanta, USA; 5th  International Conference onMedicinal Chemistry&Computer Aided Drug DesigningDecember 01-03, 2016 Chicago, USA; 2nd International Conference and Exhibition on Molecular Medicine and Diagnostics September 26-28, 2016 Miami, USA; Precision Medicine, March 7 – 9 2016,San Francisco, CA;The Personalized Medicine World Conference (PMWC) 2016, San Francisco, USA; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan; 18th International Conference on Genetics and Molecular Biology, October 10 - 11 2016, Osaka, Japan; 13th International Congress of Human Genetics, April 3-7 2016, Kyoto, Japan

  • Track 15-1Metabolomics applications in drug developments and disease study
  • Track 15-2Stem cell metabolism
  • Track 15-3Biomedical applications of computational NMR
  • Track 15-4Biomarkers research
  • Track 15-5Metabolomics screening
  • Track 15-6Signal transduction
  • Track 15-7Systems Biology approach in regulation of biochemical processes

In metabolomics, real endeavors are put resources into the advancement of suitable scientific methodologies. Metabolomics, the most youngest field in the 'omics family, is growing rapidly. Developing directly behind genomics, transcriptomics, and proteomics, metabolomics is the extensive examination of little particle metabolites. Subsequent to most metabolites are produced by enzymatic proteins that outcome from quality expression, and metabolites give creatures their biochemical attributes, the metabolome links genotype with phenotype. Metabolomics is as yet growing, however, as merchants adjust division and discovery instruments to meet its difficulties and the examination group deciphers and incorporates the mind boggling information they are gaining. The late quick advancement of a scope of investigative stages, including GC, HPLC, UPLC, CE coupled to MS and NMR spectroscopy, could empower partition, identification, portrayal and evaluation of such metabolites and related metabolic pathways. Proceeded with improvement of these diagnostic stages will quicken far reaching use and coordination of metabolomics into frameworks science. NIH Awards $1.6M to Fund microRNA Biomarker Research in Cancer, Alzheimer's Disease . The Bill and Melinda Gates Foundation today declared $7.7 million in financing for 10 new grants to identify biomarkers for diagnosing tuberculosis (TB) in low-resource settings.

Related Conferences: 2nd International Conference on Current Trends in Mass Spectrometry May 09-11, 2016 Chicago, USA; Asia Pacific Mass Spectrometry Congress October 13-15, 2016 Kuala Lumpur, Malaysia; 7th International Conference on Biomarkers&Clinical Research, November 28-30, 2016, Baltimore, USA; 7th International Conference and Exhibition on Analytical & Bioanalytical Techniques, Sept 29-Oct 01, 2016 , Miami, USA; 2nd International Conference on Genetic and Protein Engineering ,November 14-16, 2016 Atlanta, USA; LIPID MAPS Annual Meeting 2016: Lipidomics Impact on Metabolic, Cancer, Cardiovascular and Inflammatory Diseases, May 17 - 18, 2016, La Jolla, USA; 64th ASMS Conference, 5–9 June 2016  San Antonio, TX; 21st International Mass Spectrometry Conference (IMSC 2016),August 20-26, 2016,Toronto, Canada; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan

  • Track 16-1Metabolite extraction
  • Track 16-2Nuclear magnetic resonance (NMR)
  • Track 16-3Mass spectrometry
  • Track 16-4Gas chromatography–mass spectrometry (GC–MS)
  • Track 16-5Liquid chromatography–mass spectrometry (LC–MS)
  • Track 16-6Capillary electrophoresis–mass spectrometry (CE–MS)
  • Track 16-7Ratio analysis of NMR/MS

Metabolomics is one of the relative newcomers of the omics strategies and is likely the one most firmly identified with genuine ongoing infection pathophysiology. The role of metabolism in immunity has been underexplored in this way, but then scientists have made critical commitments in portraying relationship of insusceptible procedures and metabolic pathways. Systems immunology aims to study the immune system in the more integrated perspective on how entities and players participate at different system levels to the immune function. Computational immunology is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The mix of genomic data and reenactment of the motion of the resistant framework, in one single device, can offer new points of view for a superior comprehension of the safe framework. The Honorable Michelle Rempel, pastor of state for western financial expansion, today reported a venture of about $3 million toward cutting edge metabolomics evaluation gear for the U of A’s another Metabolomics Technology Demonstration Center, which is set to open in the spring of 2015.

Related Conferences: International Conference on Clinical and Molecular Genetics, November 28-30, 2016, Chicago, USA; International Conference on Cancer Immunology and Immunotherapy Conference July 28-30, 2016 Melbourne, Australia; 5th International Conference on Translational Medicine, November 17-19 2016, San Francisco , USA; 2nd International Conference and Exhibition on Molecular Medicine and Diagnostics September 26-28, 2016 Miami, USA; Epigenetic and Metabolic Regulation of Aging and Aging-Related Diseases, May 1-5, 2016,Santa Fe, USA; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan; 18th International Conference on Genetics and Molecular Biology, October 10 - 11 2016, Osaka, Japan; 13th International Congress of Human Genetics, April 3-7 2016, Kyoto, Japan.

  • Track 17-1Metabolic phenotyping in disease diagnosis
  • Track 17-2Interactions between immunity and metabolism
  • Track 17-3Computational immunology
  • Track 17-4Systems immunology
  • Track 17-5Epigenetics of trained innate immunity
  • Track 17-6Applied Immunology and immunotherapy
  • Track 17-7Application of metabolomics in autoimmune diseases

Systems biology is a field within biology aimed at understanding biological processes at the systems level and emerging from dynamic interactions of individual components operating at multiple spatiotemporal scales. Systems biology considers organic Systems by efficiently bothering them (organically, hereditarily, or artificially); observing the quality, protein, and educational pathway reactions; incorporating these information; eventually, planning numerical models that portray the structure of the framework and anticipate its reaction to individual irritations. Integrated “omics” approaches have made energizing open doors for Systems science and other organic examines. Decreases in the expense of producing genomic information have made DNA sequencing, RNA-seq, and high-throughput screening an undeniably imperative piece of biomedical exploration. The National Institute of General Medicine Sciences (NIGMS), an organization of the National Institutes of Health (NIH) supporting fundamental research and research preparing, declared not long ago that it would build up two new divisions — including one concentrated on biomedical innovation, bioinformatics, and computational biology  – – as part of a reorganization that includes the dissolution of the NIH National Center for Research Resources (NCRR) which has had a history of supporting scientific computing.

Related Conferences:7th International Conference on Biomarkers&Clinical Research, November 28-30, 2016, Baltimore, USA; 6th International Conference & Expo on Proteomics March 29-30, 2016, Atlanta, USA; 5th International Conference on Computational Systems Biology , August 22-23, 2016 Philadelphia, USA ; 2nd  International Conference on Current Trends in Mass Spectrometry May 09-11, 2016 Chicago, USA; 6th International Conference onGenomics&Pharmacogenomics, September 22-24, 2016, Berlin, Germany; The Personalized Medicine World Conference (PMWC) 2016, San Francisco, USA; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan; 18th International Conference on Genetics and Molecular Biology, October 10 - 11 2016, Osaka, Japan; 13th International Congress of Human Genetics, April 3-7 2016, Kyoto, Japan

  • Track 18-1Next generation metabolomics
  • Track 18-2Targeted metabolic profiling
  • Track 18-3Functional genomics
  • Track 18-4Data integration pathway analysis
  • Track 18-5Data mining and data analysis
  • Track 18-6Integrating gene expression and metabolomics data

Transcriptomics is the study of the transcriptome, the complete set of RNA transcripts that are delivered by the genome, under particular circumstances or in a particular cell utilizing high-throughput routines, for example, microarray analysis. The worldwide transcriptomics business sector is relied upon to develop at a CAGR of 13.7% amid the figure time of 2014 to 2019 and is evaluated to be worth $3,773.0 million by 2019. The transcriptomics market has glaringly developed in the previous couple of years essentially because of the expanding mechanical headways in the field of sequencing advances in transcriptomics research. Recent advances in metabolomic measurement technologies have been dramatic, extracting biological insight from complex metabolite profiles remains a challenge, an analytical strategy that uses data obtained from high resolution liquid chromatography–mass spectrometry and a bioinformatics toolset for detecting actively changing metabolic pathways upon external perturbation. RNA-Seq recently developed approach with transcriptome profiling that uses profound sequencing advancements. The National Human Genome Research Institute (NHGRI), which is a piece of the National Institutes of Health (NIH), has partaken in two ventures that made transcriptome assets for scientists around the globe the Mammalian Gene Collection activity and the Mouse Transcriptome Project.

Related Conferences: 5th International Conference on Translational Medicine, November 17-19, 2016 San Francisco, USA; 2nd International Conference on Transcriptomics, August 18-20, 2016 Portland, Oregon USA; 5th International Conference on Computational Systems Biology , August 22-23, 2016 Philadelphia, USA ; International Conference on Clinical and Molecular Genetics, November 28-30, 2016, Chicago, USA; 2nd International Conference and Exhibition on Molecular Medicine and Diagnostics, September 26-28, 2016 Miami, USA; The Personalized Medicine World Conference (PMWC) 2016, San Francisco, USA; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan; 18th International Conference on Genetics and Molecular Biology, October 10 - 11 2016, Osaka, Japan; 13th International Congress of Human Genetics, April 3-7 2016, Kyoto, Japan. 

  • Track 19-1Metabolomics and phytochemical genomics
  • Track 19-2Structural biology
  • Track 19-3Integration of proteomics and systems approaches
  • Track 19-4Signalling pathways
  • Track 19-5Identification of metabolites using high resolution

The rapidly growing area of "metabolomics," in which an extensive number of metabolites from body liquids, cells or tissue are identified quantitatively, in a solitary step, guarantees colossal potential for various orders including early infection conclusion, treatment checking, systems biology,drug discovery and nutritional science. In light of its capacity to distinguish countless in place organic specimens reproducibly and quantitatively, nuclear magnetic resonance (NMR) spectroscopy  has risen as a standout amongst the most intense diagnostic systems in metabolomics. Metabolon, Aglient Technologies, Thermo Scientific, Chenomx and Human Metabolome Technologies, Biocrates Life Sciences, and Metanomics are the main leaders in the metabolomics space. They are dynamic in numerous parts of this business sector: diagnostics item improvement, profiling administrations, scholarly joint efforts, and even acquisitions. Through the NIH Common Fund's Increasing Metabolomics Research Capacity program External Web Site Policy, the NIH has conferred more than $65 million to quicken the field of metabolomics throughout the following five years. The objective of this financing project is to propel a few center regions, including thorough metabolomics asset centers, metabolomics innovation improvement, metabolomics reference gauges combination, and preparing and instructive exercises in metabolomics.

Related Conferences: 2nd International Conference on Current Trends in Mass Spectrometry May 09-11, 2016 Chicago, USA; Asia Pacific Mass Spectrometry Congress October 13-15, 2016 Kuala Lumpur, Malaysia; 7th International Conference on Biomarkers&Clinical Research, November 28-30, 2016, Baltimore, USA; 7th International Conference and Exhibition on Analytical & Bioanalytical Techniques, Sept 29-Oct 01, 2016 , Miami, USA; 2nd International Conference on Genetic and Protein Engineering ,November 14-16, 2016 Atlanta, USA; LIPID MAPS Annual Meeting 2016: Lipidomics Impact on Metabolic, Cancer, Cardiovascular and Inflammatory Diseases, May 17 - 18, 2016, La Jolla, USA; 64th ASMS Conference, 5–9 June 2016  San Antonio, TX; 21st International Mass Spectrometry Conference (IMSC 2016),August 20-26, 2016,Toronto, Canada; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan

  • Track 20-1High-throughput analysis
  • Track 20-2Ultra performance liquid chromatography UPLC
  • Track 20-3NMR and LC-MS based techniques
  • Track 20-4Metabolic profiling and biomarkers
  • Track 20-5Biological signature (fingerprint) or mapping pathways
  • Track 20-6Ion mobility spectrometry for quantitative and qualitative applications

Case reports are a vital direct wellspring of confirmation in pharmaceutical and a device regularly utilized as a part of practice to trade data and create a more extended quest for proof. A decent case report will be clear about the significance of the perception being accounted for. A good case report will be clear about the importance of the observation being reported. In addition to the “evidence of what happened”, single or multiple cases are an important basis for further and more advanced research on diagnosis, treatment adequacy, reasons and results of ailment. Case reports might be first to give signs in distinguishing another ailment or unfriendly wellbeing impact from a presentation. Case reports must be authentic, understandable, educational and clinically interesting to an international audience of surgeons, trainees and researchers in all surgical subspecialties, as well as clinicians in related fields.

Related Conferences: International Conference on Case Reports, March 31-April 02, 2016 Valencia, Spain; 2nd  International Meeting on Clinical Case Reports , April 18-20, 2016 Dubai, UAE; 3rd Experts Meeting on Medical Case Reports , May 09-11, 2016 New Orleans, USA; 2nd International Conference and Exhibition on Molecular Medicine and Diagnostics, September 26-28, 2016 Miami, USA; 4th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics, September 19-21 2016, Phoenix, USA; Autumn Conference 2016 Case Report  discussion, October 15-16,2016, Birmingham, UK; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26-July 1 2016, Kyoto, Japan; 13th International Congress of Human Genetics, April 3-7 2016, Kyoto, Japan; IMPAKT  Breast Cancer Conference,  May 12-14 2016, Brussels, Belgium; International Conference on General Medicine & Dental Practise, Nov 7-9, 2016 Istanbul, Turkey; The Personalized Medicine World Conference (PMWC), May 11-13, 2016, San Francisco, USA; 

  • Track 21-1Heart diseases case reports
  • Track 21-2Cancer case reports
  • Track 21-3Diabetes case reports
  • Track 21-4Auto immune diseases case reports
  • Track 21-5Metabolomic diseases case reports
  • Track 21-6Clinical case reports

Metabolism is an essential cell procedure, and its glitch can be a noteworthy donor to numerous human sicknesses. Metabolites can serve as a metabolic ailment biomarker. A recognition of such biomarkers assumes a huge part in the investigation of biochemical response and flagging systems. Metabolic profiling, metabolomic and metabonomic concentrates for the most part include the multicomponent investigation of natural liquids, tissue and cell removes utilizing NMR spectroscopy and/or mass spectrometry (MS). Metabolic profiling (metabolomics/metabonomics) is the estimation in organic frameworks of the supplement of low-sub-atomic weight metabolites and their intermediates that mirrors the dynamic reaction to hereditary change and physiological, pathophysiological, and/or formative boosts. The current developments in metabolomics and metabolic profiling technologies have led to the discovery of several new metabolic biomarkers. Through the NIH Common Fund's Increasing Metabolomics Research Capacity programExternal Web Site Policy, the NIH has conferred more than $65 million to quicken the field of metabolomics throughout the following five years. The objective of this financing system is to propel a few center ranges, including far reaching metabolomics asset centers, metabolomics innovation improvement, metabolomics reference principles amalgamation, and preparing and instructive exercises in metabolomics.

Related Conferences:7th International Conference on Biomarkers&Clinical Research, November 28-30, 2016, Baltimore, USA; 6th International Conference & Expo on Proteomics March 29-30, 2016, Atlanta, USA; 5th International Conference on Computational Systems Biology , August 22-23, 2016 Philadelphia, USA ; 2nd  International Conference on Current Trends in Mass Spectrometry May 09-11, 2016 Chicago, USA; 6th International Conference onGenomics&Pharmacogenomics, September 22-24, 2016, Berlin, Germany; The Personalized Medicine World Conference (PMWC) 2016, San Francisco, USA; 17th International Meeting: Cell & Molecular Biology Of Chlamydomonas, June 26 - July 1 2016, Kyoto, Japan; 18th International Conference on Genetics and Molecular Biology, October 10 - 11 2016, Osaka, Japan; 13th International Congress of Human Genetics, April 3-7 2016, Kyoto, Japan

  • Track 22-1Metabolic profiling
  • Track 22-2Computational analysis of metabolic systems
  • Track 22-3importance of quantification in “omics” measurements
  • Track 22-4Metabolite biomarker testing and clinical translation
  • Track 22-5Genetic architecture of the human metabolome